Serbia lags in hematological malignancy therapies, patient group warns

The LIPA patient association claims Serbia has not advanced in treating hematological malignancies despite global progress, leaving patients without life-saving therapies. The claim is an advocacy statement, not independently verified, and highlights a potential healthcare access gap in Serbia.